Evidence map›Paper›PMID 33498837›Full record

ArticleNutrients2021

Fractalkine, sICAM-1 and Kynurenine Pathway in Restrictive Anorexia Nervosa-Exploratory Study.

Ewa Dudzińska, Kinga Szymona, Renata Kloc, Tomasz Kocki, Paulina Gil-Kulik, Jacek Bogucki, Janusz Kocki, Roman Paduch, Ewa M Urbańska

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Nutrients · 2023
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Ewa DudzińskaChair of Public Health, Medical University of Lublin, 20-090 Lublin, Poland.ORCID 0000-0003-3077-4288
Kinga SzymonaDepartment of Psychiatry, Psychotherapy and Early Intervention, Medical University of Lublin, 20-439 Lublin, Poland.
Renata KlocLaboratory of Cellular and Molecular Pharmacology, Chair and Department of Experimental and Clinical Pharmacology, Medical University of Lublin, 20-090 Lublin, Poland.
Tomasz KockiChair and Department of Experimental and Clinical Pharmacology, Medical University of Lublin, 20-090 Lublin, Poland.
Paulina Gil-KulikDepartment of Clinical Genetics, Medical University of Lublin, 20-090 Lublin, Poland.ORCID 0000-0003-3119-981X
Jacek BoguckiDepartment of Organic Chemistry, Faculty of Pharmacy, Medical University of Lublin, 20-090 Lublin, Poland.ORCID 0000-0002-8683-545X
Janusz KockiDepartment of Clinical Genetics, Medical University of Lublin, 20-090 Lublin, Poland.ORCID 0000-0002-9541-6353
Roman PaduchDepartment of Virology and Immunology, Maria Curie-Skłodowska University of Lublin, 20-033 Lublin, Poland.ORCID 0000-0001-9779-7252
Ewa M UrbańskaLaboratory of Cellular and Molecular Pharmacology, Chair and Department of Experimental and Clinical Pharmacology, Medical University of Lublin, 20-090 Lublin, Poland.
Medical University of Lublin · PL

Funding

Medical University in Lublin DS 450/17, 450/18, 450/19, 450/20
6 · The paper itself

Abstract

The link between the kynurenine pathway and immunomodulatory molecules-fractalkine and soluble intercellular adhesion molecule-1 (sICAM-1)-in anorexia nervosa (AN) remains unknown. Fractalkine, sICAM-1, tryptophan (TRP), kynurenine (KYN), neuroprotective kynurenic acid (KYNA), neurotoxic 3-OH-kynurenine (3-OH-KYN), and the expression of mRNA for kynurenine aminotransferases (

Indexed as

AdolescentAnorexia NervosaChemokine CX3CL1Cohort StudiesFemaleHumansIntercellular Adhesion Molecule-1Kynurenic AcidKynurenineMetabolic Networks and PathwaysRNA, MessengerTransaminasesTryptophanYoung Adult3-hydroxykynurenineChemokine CX3CL1ICAM1 protein, humanIntercellular Adhesion Molecule-1Kynurenic AcidKynureninekynurenine-oxoglutarate transaminaseRNA, MessengerTransaminasesTryptophaneating disorderskynurenineneuroprotectionneurotoxicity

Identifiers

PMID33498837
PMCPMC7910978
OpenAlexW3124841086

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.